Objective -To measure anxiety and depression in long term survivors of breast cancer.
patients with cancer. than by controls and significantly fewer had high scores suggesting the presence ofpsychological morbidity meriting treatment, Among the patients with cancer anxiety was more common at the first annual follow up than at later visits. Symptom scores were not significantly related to the manner of detection or to the type of initial treatm.ent. Potentially confounding social and personal factors did not account for the differences between patients with cancer and controls. Conclusion -The prevalence of anxiety and depression is not increased in long term survivors of breast cancer who are apparently free from disease and is not substantially affected by the manner in which a cancer is detected or by the treatment given. In the light of these findings it is difficult to justify large "quality adjustm.ents" to the estimates ofrecurrencefree years ofHfe saved by screening. Those who counsel patients with breast cancer should be aware that although the initial distress can be severe, meriting psychological treatm.ent, patients do recover their normal ability to enjoy life. (Journal of Medical Screening 1995; 2:5-9) Key words: psychological wellbeing; breast cancer.
Despite current interest in the use of quality adjusted life years saved (QALYs) as an outcome measure in cost effectiveness analysis of screening there has been little investigation of the quality of life of patients with breast cancer other than during the first year after diagnosis or recurrence. Economists have instead attempted to find out how other people -doctors, nurses, patients, and others -view the quality of life of hypothetical patients perceived as typical of the various states in which patients might find thernselves.P Little physical disability results from modern treatment for breast cancer, but it is widely assumed that quality of life is impaired by persistent depression or anxiety. The UK trial of early detection of breast cancer provided the opportunity, at minimal research expense, to investigate the state of wellbeing of a representative group of long term survivors of breast cancer.
Method
All women aged 50 to 64 registered with general practitioners in the South West Surrey Health District in 1979-86 were enrolled in the UK trial of early detection of breast cancer and were invited to seven annual screenings during that period. Psychiatric morbidity among women from this group who had been diagnosed with breast cancer was studied and compared with that of a control group of women without breast cancer. The patients with breast cancer were women attending a mammographic follow up clinic, held in the same premises as the screening clinic for well women. They included women whose cancer was detected by screening, others who were diagnosed symptomatically between routine rescreens, and others who had never attended for screening.
Two controls, not known to have breast cancer, were chosen for each patient with cancer from the register held by the screening clinic. They were matched with cases by year of birth and screening attendance up to the date of diagnosis of the case. General practitioners, however, had requested that the register should not be used to approach women who had never attended for screening in response to invitation, and these are therefore not represented in the control group. (For the sake of consistency, patients with cancer who had never attended before diagnosis were also excluded from the matched pair analyses.) Psychiatric morbidity was measured by the Hospital Anxiety and Depression (HAD) questionnaire, which is made up of a seven item anxiety subscale and a seven item depression subscale." Each item (for example, "I feel cheerful" is rated on a four point scale (for example, as "Not at all": 3, "Not often": 2, "Sometimes": 1, and "Most of the time": 0), giving a maximum score of 21 on each subscale. It was used because it is quick and easy to fill in without supervision and is considered a useful tool for measuring the psychological dimensions of quality of life in patients with cancer,"
The patients with breast cancer were asked to fill in the HAD questionnaire while waiting for mammography at the follow up clinic. A specialist nurse interviewed them after the x ray examination to discuss any problems they might have. Women acting as controls were sent the HAD questionnaire by post. A covering letter explained the purpose of the study and informed them that no action would be started as a result of symptoms reported on the HAD questionnaire. Non-responders were not approached again.
Information on attendance pattern, age, social class, and parity had been collected at the time of screening at the UK trial of the early detection of breast cancer and, for cancers detected during the UK trial fieldwork period up to 1987, information on the stage, mode of detection, management, and current disease status of the patients with cancer had also been collected in detail.
The odds ratio for the effect of breast cancer on risk of anxiety and depression using the thresholds recommended by the authors of the HAD questionnaire" (7/8 for borderline and 10/11 for definite anxiety or depression) were calculated by matched pair analysis (using the first selected of the two controls where both replied and the most recent HAD questionnaire EHman, Thomas filled in by the patient with cancer). Scores are not normally distributed and-hence me effects of other factors on anxiety and depression were investigated using "' I: or rank score tests of significance. Rank score tests were used to detect whether there might be differences in the prevalence of minor degrees of anxiety or inability to enjoy life, not severe enough to justify labelling as psychiatric morbidity. An unconditional logistic regression model was used to find whether differences between the patients with cancer and controls persisted after adjusting for differences in socioeconomic class, age, and parity.
Results
Of the 882 controls, 8% were excluded because they had left the district or recently died and a further 3% because their general practitioner thought they should not be included, possibly because of physical or psychiatric illness. Of the remaining eligible controls, 74·5% (584/ 784) completed the questionnaire and a further 1·5% returned an incomplete one.
Of the 441 patients with cancer, 94 were not offered an HAD questionnaire because they did not attend this clinic for follow up. Some were in the care of consultants who preferred them to receive mammographic follow up else-. where, some sought private follow up, and some were receiving active treatment, including six who were terminally ill and have since died. At least 46 of these non-attenders had had recurrences. Among those who did attend the mammographic follow up clinic, 95·4% (331/ 347) completed a questionnaire on at least one visit, leaving only 16 who were unwilling or unable to respond. Thus we have questionnaires from 76'1% (331/435) of the surviving patients with breast cancer within the registered group. Table 1 compares the characteristics of patients with cancer and controls who filled in questionnaires, contrasting them with those who did not. There were no significant differ- • Social class details were poorly recorded for some older women ("retired") and those with few attendances. Significant differences: Responding patients with cancer" responding controls: none. Responding patients with cancer" non-responding patients with cancer: screening pattern (p<0·01).
Responding controls" non-responding controls: screening pattern (p<O'05), age (p<O'05), and social class I-II" III + (P<O·OOI).
Is psychologi€al wellbeing impaired in long tenn survivors of breast cancer? ences between responding patients with cancer and responding controls in any of the variables examined. Among the controls non-responders were likely to be older (P<0'05) and to have been more irregular in attending screening (P<0·05). Patients with cancer who did not attend this follow up clinic were also less likely to have been regular attenders before their cancer was detected.
HAD SCORES OF PATIENTS WITH CANCER AND THEIR CONTROLS Tables 2 and 3 show that among the matched pairs the proportion ofsubjects scoring as cases of anxiety or depression was significantly higher among the controls than among the patients with cancer. The total scoring as cases on either or both subscales among the 290 matched pairs was 45 among the controls and 18 among the cases (P<0·001). A significant difference in scores between cases and controls still existed after adjusting for age, parity, socioeconomic group, and previous pattern of attendance for screening. 7 Among the patients with breast cancer no significant differences in anxiety or depression were detected by rank score tests between those detected by screening (n = 205) and other subgroups. Time since diagnosis did not affect depression. Anxiety was higher at the first anniversary after diagnosis than at later visits (rank score test P<0'02), but there was no significant trend between two and 13 years after diagnosis.
There was no evidence to suggest that those patients attending an annual follow up clinic whose disease had initially been called advanced, or who had been treated by more aggressive means, were any more likely to be anxious or depressed some years later than the rest (table 4). Among those who had had a recurrence of some kind depressive, but not anxiety, symptoms were more common (rank score test P<0·05). There were, however, only two who had had recurrence within the last year.
Discussion
It may be thought surprising that patients with breast cancer should report fewer symptoms of anxiety or depression than other women of similar age and background. An absence of psychiatric morbidity or symptoms of distress is, however, consistent with other studies of long term survivors of breast cancer. Vmokur et al, reporting on a sample that included 97 patients with breast cancer over five years from diagnosis, found that those without nodal disease attained the same level of physical functioning and social and psychological wellbeing as their matched controls." Similarly, Craig et al, in a study of 134 patients who had under- gone the now obsolete operation of radical mastectomy, reported that patients with breast cancer questioned at least 12 months after diagnosis could not be shown to have a significantly inferior quality of life than controls, though 3% more did report physical disability, presumably because of the extensive surgery. 7 The widely quoted statistic, that a fifth to a third of patients remain unable to come to terms with their situation, seems to be founded on two studies, both of which were relatively small, had relatively short follow up, and lacked healthy controls. In one of these 13 of 45 patients with cancer still felt psychological distress 24 months after diagnosis of the breast cancer," A follow up article entitled "The silent sadness of the 'cured' breast cancer patient"," rather than providing any evidence as to whether sadness is more common in patients with cancer, discussed the reasons given by these patients for mild sadness. The other study, a randomised trial of counselling, found that 39% of non-counselled patients but only 12% of those counselled had sufficient anxiety or depression to merit treatment at 12-18 months after diagnosis." It should, however, be remembered that about 10% of the general population might also suffer from psychiatric morbidity. Indeed the prevalence of high anxiety scores, which Hopwood et ofl found one month after treatment in patients with advanced cancer, using the HAD questionnaire, was little higher than the rate in our controls (14% 'lJ 13%), though the prevalence of depression was markedly higher (14% 'lJ 4% for our controls). Berglund et al, found a low incidence of psychological distress among 448 patients with breast cancer to whom an HAD questionnaire was sent two to 10 years after diagnosis and commented that anxiety continues to subside between 12 and 24 months."
Interpretations of why patients with chronic disease report a better state of emotional health than control subjects are varied." The explanation may be that patients who have undergone a period of extreme distress tend to use that experience as a reference point and so judge other distress as less worthy of mention, or that patients underreport their symptoms in order to normalise the perceptions of them by others.t" Spitzer et al noted that patients generally rate their quality of life higher than those who care for them. 14 As this was a low budget study those without cancer were only sent postal questionnaires, and patients with cancer attending elsewhere for follow up were not contacted. The response rate among controls was reasonably good, however, and no evidence of a response bias related to psychological morbidity in a previous study from the same group'? was demonstrable. Elsewhere HAD responses filled in at general practitioner surgeries have not been found to differ from responses to postal questionnaires."
The 25% of patients with breast cancer excluded from this study because they were not attending the mammographic follow up clinic were more likely to have active persistent or recurring cancer, and probably more likely to have been in poorer psychological health. Our Ellman, Thomas findings therefore cannot be interpreted as applying to all patients with breast cancer, but to those who one year or more after diagnosis or recurrence are apparently free from disease.
The absence of an excess of anxiety and depression in those treated more aggressively is consistent with other studies with similarly long follow up. Thus, for example, Maunsell et al found no greater morbidity after mastectomy than after an operation to conserve the breast," and Berglund et al found no differences in anxiety or depression between patients randomly allocated to chemotherapy or radiotherapy." Our study does not support the suggestion," based on anecdote, that detection by screening has an adverse effect on long term psychological outcome.
The pessimistic views of health professionals and other members of the public have been accepted in some econotnic analyses of the outcome of breast cancer treatment. Thus, though Hall et al included long term survivors in a sample of women on whose opinions they based assessments of different breast cancer scenarios, they accepted the assumption that 25% would be left with poor mental health as a consequence of the breast cancer," Quality adjustment leads to a doubling of the cost per life year saved in their estimate.
Buxton et al, also using a time trade off . method, found there was little difference between a group of doctors and nurses and a group of non-medically qualified acadetnics in the valuation of the quality of life of a hypothetical patient one year after treatment who was depicted as occasionally feeling concerned that the cancer might come back but otherwise enjoying good health and good social circumstances. 1 The mean valuation of a year of life in this state was only 70% of that of a woman in the best state of health for her age. This low estimate may have been influenced by observers' feelings about what the patient had already gone through and, possibly, a woman in the best, rather than average, state of health for her age, conjures up a picture of a superwoman that is unsuitable for comparison. Valuations by this method were similar to those produced by Torrance's"MAU" (multi-attribute utility) sys-tem19 for the same scenarios butvery much lower than valuations on the Rosser scale. The latter is not specific to a particular disease but basedon the presence ofsubjective distress and objective disability." It would rate the quality of life of Buxton's hypothetical patient as 99% that of a healthy woman but would also rate the quality of life ofa patient with a swollen arm and restricted movement, completely engulfed by fears, tearful, and unable to go out and meet people, as 91%.1 In detailed analyses of the economic effects of screening in Holland quality adjustments have been based on the views of 19 breast cancer experts and 12 other non-patients about 15 possible health states. 2 1 22 The calculated benefit of screening in terms of QALYs would have been 8% higher if instead of accepting these valuations the quality of life of long term patients with no recurrence was assumed to be unimpaired.
Arguments among economists about how best to elicit views on the quality of life of patients, and about whose opinions are the most relevant, should not divert attention from the importance of basing assessments on reliable information about the extent of distress and disability experienced by representative samples of patients with breast cancer. The quality of life of patients with cancer in this study seems to be good. Not only should this be noted by economists but it should also encourage those who counsel patients to inform them that regression of physical symptoms and emotional distress, though gradual, sometimes taking up to two years, does lead to a full resumption of the normal ability to enjoy life.
